, a bio/informatics shared resource is still "open for business" - Visit the CDS website


PGC-1 alpha serine 570 phosphorylation and GCN5-mediated acetylation by angiotensin II drive catalase down-regulation and vascular hypertrophy.

Xiong S, Salazar G, San Martin A, Ahmad M, Patrushev N, Hilenski L, Nazarewicz RR, Ma M, Ushio-Fukai M, Alexander RW
J Biol Chem. 2010 285 (4): 2474-87

PMID: 19940161 · PMCID: PMC2807304 · DOI:10.1074/jbc.M109.065235

Angiotensin II (Ang II) is a pleuripotential hormone that is important in the pathophysiology of multiple conditions including aging, cardiovascular and renal diseases, and insulin resistance. Reactive oxygen species (ROS) are important mediators of Ang II-induced signaling generally and have a well defined role in vascular hypertrophy, which is inhibited by overexpression of catalase, inferring a specific role of H(2)O(2). The molecular mechanisms are understood incompletely. The transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) is a key regulator of energy metabolism and ROS-scavenging enzymes including catalase. We show that Ang II stimulates Akt-dependent PGC-1 alpha serine 570 phosphorylation, which is required for the binding of the histone acetyltransferase GCN5 (general control nonderepressible 5) to PGC-1 alpha and for its lysine acetylation. These sequential post-translational modifications suppress PGC-1 alpha activity and prevent its binding to the catalase promoter through the forkhead box O1 transcription factor, thus decreasing catalase expression. We demonstrate that overexpression of the phosphorylation-defective mutant PGC-1 alpha (S570A) prevents Ang II-induced increases in H(2)O(2) levels and hypertrophy ([(3)H]leucine incorporation). Knockdown of PGC-1 alpha by small interfering RNA promotes basal and Ang II-stimulated ROS and hypertrophy, which is reversed by polyethylene glycol-conjugated catalase. Thus, endogenous PGC-1 alpha is a negative regulator of vascular hypertrophy by up-regulating catalase expression and thus reducing ROS levels. We provide novel mechanistic insights by which Ang II may mediate its ROS-dependent pathophysiologic effects on multiple cardiometabolic diseases.

MeSH Terms (26)

Acetylation Angiotensin II Animals Aorta, Thoracic Cardiovascular Diseases Catalase Cells, Cultured Down-Regulation Forkhead Transcription Factors Hypertrophy Luciferases Male Muscle, Smooth, Vascular Nerve Tissue Proteins p300-CBP Transcription Factors Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha Phosphorylation Promoter Regions, Genetic Protein Processing, Post-Translational Proto-Oncogene Proteins c-akt Rats Rats, Sprague-Dawley RNA-Binding Proteins Serine Transcriptional Activation Transcription Factors

Connections (1)

This publication is referenced by other Labnodes entities:

Links